Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen.
about
Emerging PSA-based tests to improve screeningCancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancerGleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results ProgramCancer/Testis Antigens: "Smart" Biomarkers for Diagnosis and Prognosis of Prostate and Other CancersGrowth hormone and prostate cancer: guilty by association?Staging prostate cancer.Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 studyProstate cancer: prediction of biochemical failure after external-beam radiation therapy--Kattan nomogram and endorectal MR imaging estimation of tumor volumeImpact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy.Temporal changes in the pathologic assessment of prostate cancer.Temporal changes in the clinical approach to diagnosing prostate cancerT2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy.Endorectal MRI after radiation therapy: questioning the sextant analysis.Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) folloDecline in the overall incidence of regional-distant prostate cancer in Olmsted County, MN, 1980-2000.Prostate carcinoma trends in three counties in Sweden 1987-1996: results from a population-based national cancer register. South-East Region Prostate Cancer Group.Nationwide, population-based study of prostate cancer stage migration between and within clinical risk categories.Annual changes in the clinical features of prostatic adenocarcinoma in Taiwan.Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
P2860
Q26828563-A051F816-2EA2-4151-830C-BC7C301836B9Q26852766-6239A4F0-BE76-4701-A3C0-3CBFAB9D74E4Q30309318-F7EF115E-1539-449A-916A-6FAFC4B6573AQ33399255-A59A8726-4B57-428C-9CD7-6C30DBE81C00Q33517492-E00FBE3F-B680-4166-B554-78EF3450D888Q33624448-CA0CF407-058C-445C-B230-8291CDE947BCQ33708557-A5E93331-B27B-455B-A1B7-BCA86FCA0F54Q34080722-3A132E03-0FB6-4C36-95FC-D2A55FB93EDAQ34179268-B0AAECB9-9DB2-4ADC-91C5-AA3DFA8B4DC3Q35407313-4337ABF5-F9C4-43FD-8CA8-75EC747536DDQ36385264-62EB35A6-EA1B-41DC-A0C6-D4676CE64543Q36520474-F7897690-AF3C-41C5-96F1-65C4ADA7079BQ36520528-94FFF2C2-4071-49D1-8A7B-09059D56CA76Q37466785-B6A4B8E8-7599-4E55-A2D1-E6741E8B8DCAQ37867597-2947B52F-C539-42F1-AC17-46C30CA4097BQ38491112-39331F85-C5EF-4D12-A4D7-97812D71416CQ38546301-4FE4BCFF-604A-42C4-B3A9-FBAE1BE7C532Q39512565-A9B1F656-5344-4CDE-9327-7DA7001C76A2Q43994626-A6019627-01DC-458E-A55A-FD891AE2BCA6Q44184008-90F4BEF6-0730-4543-9C18-9EB7DDCB9BABQ45742174-90FEEAD8-B9AF-45B7-98E1-619CAA34B9FEQ50668698-1A0A22A2-E629-457B-BCDC-74BA07EA5DBBQ51496034-2035A244-ADEC-46E4-92D2-9DE1010D0B3A
P2860
Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Population-based prostate canc ...... of prostate-specific antigen.
@en
type
label
Population-based prostate canc ...... of prostate-specific antigen.
@en
prefLabel
Population-based prostate canc ...... of prostate-specific antigen.
@en
P356
P1476
Population-based prostate canc ...... of prostate-specific antigen.
@en
P2093
Stanford JL
Stephenson RA
P2888
P304
P356
10.1007/BF01300179
P577
1997-01-01T00:00:00Z
P6179
1003554631